QID 50125

Date Published: 2023-02-15

QID 50125: Microsoft Exchange Server Remote Code Execution (RCE) Vulnerability for February 2023

Microsoft Exchange Server 2013, 2016 and 2019 are affected by multiple vulnerabilities.

KB Articles associated with this update are: KB5023038

Affected Versions:
Microsoft Exchange Server 2013 Cumulative Update 23
Microsoft Exchange Server 2016 Cumulative Update 23
Microsoft Exchange Server 2019 Cumulative Update 11
Microsoft Exchange Server 2019 Cumulative Update 12

QID Detection Logic (Authenticated):
The QID checks for vulnerable version of Microsoft Exchange Server by checking the file version of Exsetup.exe.

Successful exploitation of the vulnerability may allow remote code execution

CVSS V3 rated as Critical - 8.8 severity.

CVSS V2 rated as Critical - 8.3 severity.

Solution

Microsoft has released patch, customers are advised to refer to KB5023038 for information pertaining to this vulnerability.

Vendor References

CVE-2023-21529 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2023-21529
CVE-2023-21706 - msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2023-21706
CVE-2023-21707 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2023-21707
CVE-2023-21710 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2023-21710

CVEs related to QID 50125

CVE-2023-21707 | CVE-2023-21529 | CVE-2023-21706 | CVE-2023-21710 |

Software Advisories

Advisory ID	Software	Component	Link
KB5023038			support.microsoft.com/en-us/topic/description-of-the-security-update-for-microsoft-exchange-server-2019-2016-and-2013-february-14-2023-kb5023038-2e60d338-dda3-46ed-aed1-4a8bbee87d23

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].